Product Images Clorazepate Dipotassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Clorazepate Dipotassium NDC 13107-282 by Aurolife Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 3.75 mg 100 Tablets Container Label - clorazepate fig1

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 3.75 mg 100 Tablets Container Label - clorazepate fig1

Each tablet contains 3.75 mg of Clorazepate dipotassium. This medication is distributed by Aurobindo Pharma USA, Inc. and is kept in a light-resistant container. The tablets are made in India and should be stored at a temperature of 20° to 25°C (68° to 77°F). It is important to keep the container tightly closed and protect the medication from light and moisture. This medication is only available with a prescription and should be kept out of reach of children. A medication guide is available separately for each patient.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (100 Tablets Bottle) - clorazepate fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (100 Tablets Bottle) - clorazepate fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (100 Tablets Bottle) - clorazepate fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 7.5 mg (100 Tablets Bottle) - clorazepate fig3

CHemical Structure - clorazepate str

CHemical Structure - clorazepate str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.